Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
16.34
+0.47 (2.96%)
Jun 3, 2026, 11:52 AM EDT - Market open
Viridian Therapeutics Employees
Viridian Therapeutics had 252 employees as of December 31, 2025. The number of employees increased by 109 or 76.22% compared to the previous year.
Employees
252
Change (1Y)
109
Growth (1Y)
76.22%
Revenue / Employee
$281,421
Profits / Employee
-$1,203,440
Market Cap
1.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 252 | 109 | 76.22% | 252 | 0 |
| Dec 31, 2024 | 143 | 49 | 52.13% | 143 | 0 |
| Dec 31, 2023 | 94 | 8 | 9.30% | 94 | 0 |
| Dec 31, 2022 | 86 | 36 | 72.00% | 86 | 0 |
| Dec 31, 2021 | 50 | 23 | 85.19% | 50 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| ADMA Biologics | 647 |
| Vericel | 398 |
| Nuvation Bio | 307 |
| Harmony Biosciences Holdings | 293 |
| Zymeworks | 243 |
| Stoke Therapeutics | 170 |
VRDN News
- 2 days ago - Viridian Therapeutics Slides: Corporate presentation - Filings
- 7 days ago - Viridian Therapeutics to Participate in Upcoming June Investor Conferences - Business Wire
- 14 days ago - Viridian Metals Expands Drill Program to 50 Holes at Kraken Copper-Nickel Project - GlobeNewsWire
- 19 days ago - Viridian Therapeutics price target lowered to $26 from $27 at Evercore ISI - TheFly
- 20 days ago - Viridian Metals Announces Flow-Through Private Placement, Warrant Extension and Date of Annual General and Special Meeting - GlobeNewsWire
- 20 days ago - Viridian Therapeutics price target lowered to $39 from $48 at Stifel - TheFly
- 27 days ago - Viridian Therapeutics 7.353M share Spot Secondary priced at $17.00 - TheFly
- 27 days ago - Viridian Therapeutics price target raised to $34 from $30 at RBC Capital - TheFly